Barinthus Biotherapeutics plc. (BRNS) › Operating Cash FlowBarinthus Biotherapeutics plc. (BRNS) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2020: -$11.03M2021: -$32.58M2022: -$14.43M2023: -$50.92M2024: -$28.94M2025: -$47.98M-$47.98M2020Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$47.98M-65.8%2024-$28.94M+43.2%2023-$50.92M-252.9%2022-$14.43M+55.7%2021-$32.58M-195.5%2020-$11.03M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share